ArticleBMC infectious diseases2023

Optimizing (O) rifapentine-based (RI) regimen and shortening (EN) the treatment of drug-susceptible tuberculosis (T) (ORIENT) using an adaptive seamless design: study protocol of a multicenter randomized controlled trial.

Zhen Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.